[1] YAMAMIYA A,KITAMURA K,ISHII Y,et al. Feasibility of initial endoscopic common bile duct stone removal in patients with acute cholangitis[J]. World J Clin Cases,2017,5(7):280-285.
|
[2] LI YL,WONG KH,CHIU KW,et al. Percutaneous cholecystostomy for high-risk patients with acute cholangitis[J].Medicine,2018,97(19):e0735.
|
[3] WANG CQ,MA YC,ZHU ZY,et al. Risk factors for pyogenic cholangitis in patients with common bile duct stones[J]. J Clin Hepatol,2017,33(1):95-97.(in Chinese)王春秋,马颖才,朱智勇,等.胆总管结石患者并发化脓性胆管炎的预警因素分析[J].临床肝胆病杂志,2017,33(1):95-97.
|
[4] TAN M,OB SDM,LAURSEN SB. Association between early ERCP and mortality in patients with acute cholangitis[J]. Gastrointest Endosc,2017,87(1):185-192.
|
[5] ISAYAMA H,YASUDA I,TAN D. Current strategies for endoscopic management of acute cholangitis[J]. Dig Endosc,2017,29(S2):70-77.
|
[6] SAWAS T,ARWANI N,AL HS,et al. Sphincterotomy with endoscopic biliary drainage for severe acute cholangitis:A meta-analysis[J]. Endosc Int Open,2017,5(2):e103-e109.
|
[7] ZHENG C,HUANG Y,XIE E,et al. Laparoscopic common bile duct exploration:A safe and definitive treatment for elderly patients[J]. Surg Endosc,2017,31(6):2541-2547.
|
[8] KALIMI R,COSGROVE JM,MARINI C,et al. Combined intraoperative laparoscopic cholecystectomy and endoscopic retrograde cholangiopancreatography[J]. Surg Endosc,2000,14(3):232-234.
|
[9] LIU MY,SUN MJ. Emergency ERCP in the management of acute obstructive cholangitis and biliary pancreatitis[J]. Chin J Med Surg,2017,45(5):504-507.(in Chinese)刘梦园,孙明军.急诊内镜下逆行胰胆管造影术治疗急性梗阻性胆管炎及胆源性胰腺炎疗效分析[J].临床军医杂志,2017,45(5):504-507.
|
[10] SUWA Y,MATSUYAMA R,GOTO K,et al. IL-7 and procalcitonin are useful biomarkers in the comprehensive evaluation of the severity of acute cholangitis[J]. J Hepatobiliary Pancreat Sci,2017,24(2):81-88.
|
[11] VIJAYAN AL,VANIMAYA,RAVINDRAN S,et al. Procalcitonin:A promising diagnostic marker for sepsis and antibiotic therapy[J]. J Intensive Care,2017,5:51.
|
[12] ZHANG XX,SUN XL,WANG GX. Correlation between changes of PCT and PLT and severity of acute obstructive suppurative cholangitis[J]. J Clin Exp Med,2019,18(8):887-891.(in Chinese)张晓曦,孙雪莲,王国兴.降钙素原和血小板计数变化与急性梗阻性化脓性胆管炎患者病情严重程度的相关性分析[J].临床和实验医学杂志,2019,18(8):887-891.
|
[13] ZHAO BQ,CHEN YQ,ZHENG MF. Former of calcitonin and whole body inflammatory response syndrome[J]. Med Recapitu-late,2014,10(2):74-75.
|
[14] UMEFUNE G,KOGURE H,HAMADA T,et al. Procalcitonin is a useful biomarker to predict severe acute cholangitis:A single-center prospective study[J]. J Gastroenterol,2017,52(6):734-745.
|
[15] LUO G,JIN K,CHENG H,et al. Carbohydrate antigen 199 as a prognostic biomarker in pancreatic neuroendocrine tumors[J]. Oncol Lett,2017,14(6):6795-6800.
|
[16] ZHANG Y,JIANG L,SONG L. Meta-analysis of diagnostic value of serum carbohydrate antigen 199(CA199)in pancreatic cancer.[J]. Minerva Med,2016,107(1):62-69.
|
[17] YAN W,XU L,WANG YJ,et al. A case report of spontaneous rupture of intracranial epidermoid cyst with dramatic increase of serum carbohydrate antigen 199:A three-year follow-up study[J]. BMC Neurology,2015,15(1):1-4.
|
[18] MICKE O,BRUNS F,KUROWSKI R,et al. Predictive value of carbohydrate antigen 19-9 in pancreatic cancer treated with radiochemotherapy[J]. Int J Radiat Oncol Biol Phys,2003,57(1):90-97.
|
[19] KAJBAFZADEH AM,KEIHANI S,KAMELI SM,et al. Maternal urinary carbohydrate antigen 19-9 as a novel biomarker for evaluating fetal hydronephrosis:A pilot study[J]. Urology,2017,101:90-93.
|
[20] MEI Y,CHEN L,PENG CJ,et al. Diagnostic value of elevated serum carbohydrate antigen 199 level in acute cholangitis secondary to choledocholithiasis[J]. World J Clin Cases,2018,6(11):441-446.
|